Literature DB >> 30878791

Topographic deficits in sleep spindle density and duration point to frontal thalamo-cortical dysfunctions in first-episode psychosis.

Rachel E Kaskie1, Bianca Graziano1, Fabio Ferrarelli2.   

Abstract

Sleep spindles are NREM sleep EEG oscillations, which are initiated within the thalamus and are regulated by thalamo-cortical circuits. Previous work from our and other research groups has shown marked spindle deficits in patients with schizophrenia (SCZ). However, the presence of spindle impairments at illness onset, including which parameters are most affected, their topographic characteristics, and their relationships with clinical symptoms have yet to be characterized. In this study we performed sleep high density (hd)-EEG recordings in twenty-seven first-episode psychosis (FEP) patients and twenty-three healthy controls (HC). Several spindle parameters-amplitude, duration, and density-were calculated and compared across groups. FEP patients showed reduced spindle duration and density, but not in spindle amplitude relative to HC. These spindles reductions were localized in a frontal area and predicted the severity of FEP patients' negative symptoms. Altogether, these findings indicate that spindle deficits are present at the beginning of psychosis, contribute to clinical symptomatology, and point to frontal thalamo-cortical dysfunctions, thus providing a potential treatment target for early interventions in SCZ and related psychotic disorders.
Copyright © 2019. Published by Elsevier Ltd.

Entities:  

Mesh:

Year:  2019        PMID: 30878791     DOI: 10.1016/j.jpsychires.2019.03.009

Source DB:  PubMed          Journal:  J Psychiatr Res        ISSN: 0022-3956            Impact factor:   4.791


  10 in total

1.  Sleep Researchers are Studying Addiction but Don't Know It.

Authors:  Harold W Gordon
Journal:  Arch Neurol Neurosci       Date:  2019-12-05

2.  Sleep spindle and slow wave abnormalities in schizophrenia and other psychotic disorders: Recent findings and future directions.

Authors:  Yingyi Zhang; Gonzalo M Quiñones; Fabio Ferrarelli
Journal:  Schizophr Res       Date:  2019-11-18       Impact factor: 4.939

Review 3.  Sleep disturbances in schizophrenia: what we know, what still needs to be done.

Authors:  Rachel E Kaskie; Fabio Ferrarelli
Journal:  Curr Opin Psychol       Date:  2019-09-27

4.  Sleep abnormalities in individuals at clinical high risk for psychosis.

Authors:  Ahmad Mayeli; Alice LaGoy; Francesco L Donati; Rachel E Kaskie; Seyed Morteza Najibi; Fabio Ferrarelli
Journal:  J Psychiatr Res       Date:  2021-03-08       Impact factor: 4.791

5.  Reduced GABA/glutamate in the thalamus of individuals at clinical high risk for psychosis.

Authors:  Gonzalo M Quiñones; Ahmad Mayeli; Victor E Yushmanov; Hoby P Hetherington; Fabio Ferrarelli
Journal:  Neuropsychopharmacology       Date:  2020-12-03       Impact factor: 7.853

6.  Systematic review: the relationship between sleep spindle activity with cognitive functions, positive and negative symptoms in psychosis.

Authors:  Chi Hung Au; Christopher-James Harvey
Journal:  Sleep Med X       Date:  2020-08-29

Review 7.  The nature, consequences, mechanisms, and management of sleep disturbances in individuals at-risk for psychosis.

Authors:  Feten Fekih-Romdhane; Souheil Hallit; Majda Cheour; Haitham Jahrami
Journal:  Front Psychiatry       Date:  2022-09-20       Impact factor: 5.435

Review 8.  Sleep Abnormalities in Schizophrenia: State of the Art and Next Steps.

Authors:  Fabio Ferrarelli
Journal:  Am J Psychiatry       Date:  2021-03-17       Impact factor: 18.112

Review 9.  The Engram's Dark Horse: How Interneurons Regulate State-Dependent Memory Processing and Plasticity.

Authors:  Frank Raven; Sara J Aton
Journal:  Front Neural Circuits       Date:  2021-09-13       Impact factor: 3.492

10.  Sleep, sleep spindles, and cognitive functions in drug-naive patients with first-episode psychosis.

Authors:  Naksidil Torun Yazıhan; Sinan Yetkin
Journal:  J Clin Sleep Med       Date:  2020-12-15       Impact factor: 4.062

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.